Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus
We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016....
Saved in:
Published in | Radiation oncology journal Vol. 35; no. 3; pp. 268 - 273 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society for Radiation Oncology
01.09.2017
대한방사선종양학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2234-1900 2234-3156 2234-3156 2234-3164 |
DOI | 10.3857/roj.2017.00199 |
Cover
Abstract | We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.
We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm
(range, 6.8-83.2 cm
), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy.
The median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy.
Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus. |
---|---|
AbstractList | We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.
We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm
(range, 6.8-83.2 cm
), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy.
The median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy.
Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus. Purpose: We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy. Materials and Methods: We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31–65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm3 (range, 6.8–83.2 cm3), and fractionated radiation was administered to a total dose of 50–54 Gy with a daily dose of 2 Gy. Results: The median follow-up period was 6.8 years (range, 2.2–8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9–95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy. Conclusion: Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus. KCI Citation Count: 0 We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.PURPOSEWe performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.We analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm3 (range, 6.8-83.2 cm3), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy.MATERIALS AND METHODSWe analyzed 10 patients with hemangioma of the cavernous sinus who were treated with conventional radiotherapy between January 2000 and December 2016. The median patient age was 54 years (range, 31-65 years), and 8 patients (80.0%) were female. The mean hemangioma volume was 34.1 cm3 (range, 6.8-83.2 cm3), and fractionated radiation was administered to a total dose of 50-54 Gy with a daily dose of 2 Gy.The median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy.RESULTSThe median follow-up period was 6.8 years (range, 2.2-8.8 years). At last follow-up, the volume of the tumor had decreased in all patients. The average tumor volume reduction rate from the initial volume was 72.9% (range, 18.9-95.3%). All 10 of the cranial neuropathies observed before radiation therapy had improved, with complete symptomatic remission in 9 cases (90%) and partial remission in 1 case (10%). No new acute neurologic impairments were reported after radiotherapy. One probable compressive optic neuropathy was observed at 1 year after radiotherapy.Fractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus.CONCLUSIONFractionated radiotherapy achieves both symptomatic and radiologic improvements. It is a well-tolerated treatment modality for hemangiomas of the cavernous sinus. |
Author | Yoon, Sang Min Song, Si Yeol Park, Jin-hong Choi, Eun Kyung Ahn, Seung Do Lee, Sumin Lee, Sang-wook Kim, Jong Hoon Park, Sunmin |
Author_xml | – sequence: 1 givenname: Sunmin surname: Park fullname: Park, Sunmin – sequence: 2 givenname: Sang Min surname: Yoon fullname: Yoon, Sang Min – sequence: 3 givenname: Sumin surname: Lee fullname: Lee, Sumin – sequence: 4 givenname: Jin-hong surname: Park fullname: Park, Jin-hong – sequence: 5 givenname: Si Yeol surname: Song fullname: Song, Si Yeol – sequence: 6 givenname: Sang-wook surname: Lee fullname: Lee, Sang-wook – sequence: 7 givenname: Seung Do surname: Ahn fullname: Ahn, Seung Do – sequence: 8 givenname: Jong Hoon surname: Kim fullname: Kim, Jong Hoon – sequence: 9 givenname: Eun Kyung surname: Choi fullname: Choi, Eun Kyung |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29037018$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002267247$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqFkc1v3CAQxVGVqknTXHusOLaH3QwYsLlUiqJ-RIpUKdqeEcY4S2KDCzjR_vfF2e2nVJXLIPF785g3L9GRD94i9JrAump4fR7D3ZoCqdcARMpn6ITSiq0qwsXR4U4kwDE6S-kOyhHAhYAX6JhKqGogzQna3ITB4tDjPmqTXfA62w5H3bmQtzbqaYedx5POzvqc8KPLW7y1o_a3Lox6ERYMG_1gow9zwsn5Ob1Cz3s9JHt2qKfo68cPm8vPq-svn64uL65XhlGWV7QlBFj5YtcKEJ0AQ3rouKbEsLprbW9aZghUhFYNbS2vaya7tgVuQBLWyOoUvdv39bFX98apoN1TvQ3qPqqLm82VokKCbHhhz_fs7Ce9e9TDoKboRh13ioBa4lQlTrXEqZ7iLIr3e8U0t6PtTAkg6l-qxevPF--2xflBccHqmtPS4O2hQQzfZpuyGl0ydhi0tyUrRSSnBISgTUHf_O710-THogrA9oCJIaVoe2Vc1svCirUb_j3D-i_Zf4b-DoTvt5U |
CitedBy_id | crossref_primary_10_1080_02688697_2021_1958154 crossref_primary_10_3390_cancers15071999 crossref_primary_10_3892_etm_2024_12763 crossref_primary_10_1016_j_wneu_2018_11_015 crossref_primary_10_3171_2021_7_JNS21955 crossref_primary_10_1016_j_wneu_2018_12_185 crossref_primary_10_1016_j_wneu_2023_07_068 crossref_primary_10_1186_s12894_019_0441_0 crossref_primary_10_3389_fneur_2020_00355 crossref_primary_10_1016_j_wneu_2017_11_177 crossref_primary_10_1007_s43465_020_00295_0 crossref_primary_10_1227_ons_0000000000000180 |
Cites_doi | 10.1016/0360-3016(91)90171-Y 10.3171/foc.2006.21.1.7 10.1016/j.clineuro.2014.09.025 10.1007/s00066-006-1473-4 10.4103/0973-029X.141321 10.2176/nmc.40.575 10.1007/BF00314842 10.1007/s11060-011-0753-8 10.3892/ol.2015.4053 10.3171/jns.1987.67.6.0919 10.1227/01.NEU.0000124750.13721.94 10.1007/s00701-015-2657-4 10.1016/j.ijrobp.2011.12.051 10.1227/00006123-199008000-00024 10.1097/00006123-199201000-00018 10.2176/nmc.32.93 10.1016/j.ijrobp.2009.07.1753 10.1227/01.NEU.0000378026.23116.E6 10.1007/s11060-014-1414-5 10.3171/2009.6.JNS08271 10.1007/s00066-004-1266-6 |
ContentType | Journal Article |
Copyright | Copyright © 2017. The Korean Society for Radiation Oncology 2017 |
Copyright_xml | – notice: Copyright © 2017. The Korean Society for Radiation Oncology 2017 |
DBID | AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY ACYCR |
DOI | 10.3857/roj.2017.00199 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2234-3156 2234-3164 |
EndPage | 273 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2690985 10.3857/roj.2017.00199 PMC5647752 29037018 10_3857_roj_2017_00199 |
Genre | Journal Article |
GroupedDBID | 5-W 8JR 8XY 9ZL AAKDD AAYXX ABDBF ACUHS ADBBV ADRAZ AEGXH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK EF. GX1 HYE KQ8 M48 OK1 PGMZT RPM KVFHK NPM 7X8 5PM ADTOC UNPAY .UV ACYCR |
ID | FETCH-LOGICAL-c424t-2b1104190db606d60c1f0d5a21c47dbefcb4c10312382be57749dbb05c0914893 |
IEDL.DBID | M48 |
ISSN | 2234-1900 2234-3156 |
IngestDate | Tue Nov 21 21:43:11 EST 2023 Wed Aug 20 00:16:04 EDT 2025 Thu Aug 21 17:57:30 EDT 2025 Fri Jul 11 14:45:21 EDT 2025 Wed Feb 19 02:43:53 EST 2025 Tue Jul 01 01:32:54 EDT 2025 Thu Apr 24 23:00:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Cavernous sinus Radiotherapy Hemangioma |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c424t-2b1104190db606d60c1f0d5a21c47dbefcb4c10312382be57749dbb05c0914893 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3857/roj.2017.00199 |
PMID | 29037018 |
PQID | 1952106628 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2690985 unpaywall_primary_10_3857_roj_2017_00199 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5647752 proquest_miscellaneous_1952106628 pubmed_primary_29037018 crossref_citationtrail_10_3857_roj_2017_00199 crossref_primary_10_3857_roj_2017_00199 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-09-01 |
PublicationDateYYYYMMDD | 2017-09-01 |
PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Radiation oncology journal |
PublicationTitleAlternate | Radiat Oncol J |
PublicationYear | 2017 |
Publisher | The Korean Society for Radiation Oncology 대한방사선종양학회 |
Publisher_xml | – name: The Korean Society for Radiation Oncology – name: 대한방사선종양학회 |
References | ref13 ref12 ref15 ref14 ref20 ref11 ref10 ref21 ref2 ref1 ref17 ref16 ref19 ref18 ref8 ref7 ref9 ref4 ref3 ref6 ref5 11109795 - Neurol Med Chir (Tokyo). 2000 Nov;40(11):575-80 25364160 - J Oral Maxillofac Pathol. 2014 Sep;18(Suppl 1):S117-20 9007890 - Neurosurg Rev. 1996;19(4):261-4 26658989 - Acta Neurochir (Wien). 2016 Feb;158(2):313-8 3681431 - J Neurosurg. 1987 Dec;67(6):919-22 16520913 - Strahlenther Onkol. 2006 Mar;182(3):179-82 15157295 - Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4 22361080 - Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e223-30 15592695 - Strahlenther Onkol. 2004 Dec;180(12):758-67 26893777 - Oncol Lett. 2016 Feb;11(2):1545-1548 2385350 - Neurosurgery. 1990 Aug;27(2):306-10 22086238 - J Neurooncol. 2012 Apr;107(2):239-45 20171514 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S28-35 25459244 - Clin Neurol Neurosurg. 2014 Dec;127:59-64 16859259 - Neurosurg Focus. 2006 Jul 15;21(1):e6 1738435 - Neurosurgery. 1992 Jan;30(1):101-8 20647963 - Neurosurgery. 2010 Sep;67(3):611-6; discussion 616 24584749 - J Neurooncol. 2014 May;118(1):163-8 1376867 - Neurol Med Chir (Tokyo). 1992 Feb;32(2):93-5 19612972 - J Neurosurg. 2010 Apr;112(4):772-9 2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22 |
References_xml | – ident: ref21 doi: 10.1016/0360-3016(91)90171-Y – ident: ref3 doi: 10.3171/foc.2006.21.1.7 – ident: ref17 doi: 10.1016/j.clineuro.2014.09.025 – ident: ref11 doi: 10.1007/s00066-006-1473-4 – ident: ref1 doi: 10.4103/0973-029X.141321 – ident: ref5 doi: 10.2176/nmc.40.575 – ident: ref9 doi: 10.1007/BF00314842 – ident: ref13 doi: 10.1007/s11060-011-0753-8 – ident: ref16 doi: 10.3892/ol.2015.4053 – ident: ref6 doi: 10.3171/jns.1987.67.6.0919 – ident: ref10 doi: 10.1227/01.NEU.0000124750.13721.94 – ident: ref15 doi: 10.1007/s00701-015-2657-4 – ident: ref12 doi: 10.1016/j.ijrobp.2011.12.051 – ident: ref7 doi: 10.1227/00006123-199008000-00024 – ident: ref4 doi: 10.1097/00006123-199201000-00018 – ident: ref8 doi: 10.2176/nmc.32.93 – ident: ref20 doi: 10.1016/j.ijrobp.2009.07.1753 – ident: ref2 doi: 10.1227/01.NEU.0000378026.23116.E6 – ident: ref14 doi: 10.1007/s11060-014-1414-5 – ident: ref18 doi: 10.3171/2009.6.JNS08271 – ident: ref19 doi: 10.1007/s00066-004-1266-6 – reference: 20171514 - Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S28-35 – reference: 22086238 - J Neurooncol. 2012 Apr;107(2):239-45 – reference: 26893777 - Oncol Lett. 2016 Feb;11(2):1545-1548 – reference: 15592695 - Strahlenther Onkol. 2004 Dec;180(12):758-67 – reference: 26658989 - Acta Neurochir (Wien). 2016 Feb;158(2):313-8 – reference: 25459244 - Clin Neurol Neurosurg. 2014 Dec;127:59-64 – reference: 1376867 - Neurol Med Chir (Tokyo). 1992 Feb;32(2):93-5 – reference: 25364160 - J Oral Maxillofac Pathol. 2014 Sep;18(Suppl 1):S117-20 – reference: 20647963 - Neurosurgery. 2010 Sep;67(3):611-6; discussion 616 – reference: 16520913 - Strahlenther Onkol. 2006 Mar;182(3):179-82 – reference: 22361080 - Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e223-30 – reference: 9007890 - Neurosurg Rev. 1996;19(4):261-4 – reference: 3681431 - J Neurosurg. 1987 Dec;67(6):919-22 – reference: 2032882 - Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22 – reference: 15157295 - Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4 – reference: 11109795 - Neurol Med Chir (Tokyo). 2000 Nov;40(11):575-80 – reference: 24584749 - J Neurooncol. 2014 May;118(1):163-8 – reference: 1738435 - Neurosurgery. 1992 Jan;30(1):101-8 – reference: 2385350 - Neurosurgery. 1990 Aug;27(2):306-10 – reference: 19612972 - J Neurosurg. 2010 Apr;112(4):772-9 – reference: 16859259 - Neurosurg Focus. 2006 Jul 15;21(1):e6 |
SSID | ssj0000605660 |
Score | 2.1138072 |
Snippet | We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.
We... We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.PURPOSEWe... Purpose: We performed this retrospective study to investigate the outcomes of patients with hemangioma of the cavernous sinus after fractionated radiotherapy.... |
SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 268 |
SubjectTerms | Original 방사선과학 |
Title | Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29037018 https://www.proquest.com/docview/1952106628 https://pubmed.ncbi.nlm.nih.gov/PMC5647752 https://www.e-roj.org/upload/pdf/roj-2017-00199.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002267247 |
UnpaywallVersion | publishedVersion |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Radiation oncology journal , 2017, 35(3), , pp.268-273 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2234-3156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: KQ8 dateStart: 20110101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2234-3156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: ABDBF dateStart: 20120901 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2234-3156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2234-3156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2234-3156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: 5-W dateStart: 20110101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 2234-3156 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: RPM dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2234-3156 dateEnd: 20250630 omitProxy: true ssIdentifier: ssj0000605660 issn: 2234-1900 databaseCode: M48 dateStart: 20120901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVoOcAFgSgQCpWLKpWLkeM6m-SAEEJULVI5oK7Um-XPkjZ12mRXsP-emSRdumIRnKLIk1iesTNvHM8bQvac8JifyJn23DHpJhNmciuZC0IEWIEm9xgonnydHE3ll7Ps7Pf5p1GB3drQDutJTdv63c-bxQdY8O8x4iwgoG-bCzyjhVyEaVlukPvglQTO8JMR6g9fZXD1fdIwOETJwA_ygcNxzStWfNRGbMM6-PnnKcoH83itFz90Xd9xUYePyaMRW9KPw2R4Qu75-JScfmtqT5tAQzvkMAC4dLTVrhpzrxa0inSkV-0o7stSJHKN51VzpfFBEKNWY0neZt7RrorzbotMDz-ffjpiYykFZqWQMyYMuHkJg3YGIhY34TYN3GVapFbmzvhgjbRY8QE8uDA-A1BYOmN4ZgFPID_NM7IZm-hfEKpLnxuuCxkgOJSZL4Q3NnUh8ML6ojAJYbfKU3bkGcdyF7WCeAOVrUDZCpWtemUnZH8pfz0wbPxV8g3YQl3aSiEpNl7PG3XZKoD-x0pAnF8WWUJ2b02lYKXg7w8dPehHpSVAFSS8LxLyfDDdskNR8oOcp9CSrxh1KYAdrrbE6nvPxp1hKm8mEvJ2af5_jOPlf494mzzEm-FM2yuyOWvn_jWAoJnZ6Wf3Tr879QsOsAWf |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+fractionated+radiotherapy+in+patients+with+hemangioma+of+the+cavernous+sinus&rft.jtitle=Radiation+oncology+journal&rft.au=Park%2C+Sunmin&rft.au=Yoon%2C+Sang+Min&rft.au=Lee%2C+Sumin&rft.au=Park%2C+Jin-hong&rft.date=2017-09-01&rft.issn=2234-1900&rft.eissn=2234-3156&rft.volume=35&rft.issue=3&rft.spage=268&rft.epage=273&rft_id=info:doi/10.3857%2Froj.2017.00199&rft.externalDBID=n%2Fa&rft.externalDocID=10_3857_roj_2017_00199 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-1900&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-1900&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-1900&client=summon |